BR112014020171A2 - método para desinfecção de um animal, método para reduzir a quantidade de campylobacter na carne, método para identificar um composto para uso na desinfecção de animais, prevenção ou redução da adesão de campylobacter à parede intestinal ou no tratamento de infecção por campylobacter em humanos ou animais, alimento animal, ingrediente de alimento ou suplemento alimentar, método para desinfectar um gênero alimentício, composto, uso de um composto e kit - Google Patents
método para desinfecção de um animal, método para reduzir a quantidade de campylobacter na carne, método para identificar um composto para uso na desinfecção de animais, prevenção ou redução da adesão de campylobacter à parede intestinal ou no tratamento de infecção por campylobacter em humanos ou animais, alimento animal, ingrediente de alimento ou suplemento alimentar, método para desinfectar um gênero alimentício, composto, uso de um composto e kitInfo
- Publication number
- BR112014020171A2 BR112014020171A2 BR112014020171A BR112014020171A BR112014020171A2 BR 112014020171 A2 BR112014020171 A2 BR 112014020171A2 BR 112014020171 A BR112014020171 A BR 112014020171A BR 112014020171 A BR112014020171 A BR 112014020171A BR 112014020171 A2 BR112014020171 A2 BR 112014020171A2
- Authority
- BR
- Brazil
- Prior art keywords
- disinfecting
- campylobacter
- food
- compost
- animals
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title 4
- 230000000249 desinfective effect Effects 0.000 title 3
- 241000589876 Campylobacter Species 0.000 title 2
- 239000002361 compost Substances 0.000 title 2
- 206010051226 Campylobacter infection Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 235000015872 dietary supplement Nutrition 0.000 title 1
- 235000013305 food Nutrition 0.000 title 1
- 235000012041 food component Nutrition 0.000 title 1
- 239000005417 food ingredient Substances 0.000 title 1
- 230000000968 intestinal effect Effects 0.000 title 1
- 235000013372 meat Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1202681.1A GB201202681D0 (en) | 2012-02-16 | 2012-02-16 | Reduction of gastrointestinal tract colonisation by campylobacter |
| GB1202681.1 | 2012-02-16 | ||
| GBGB1220158.8A GB201220158D0 (en) | 2012-11-08 | 2012-11-08 | Reduction of gastrointestinal tract colonisation by campylobacter |
| GB1220158.8 | 2012-11-08 | ||
| PCT/GB2013/050367 WO2013121214A1 (en) | 2012-02-16 | 2013-02-15 | Reduction of gastrointestinal tract colonisation by campylobacter |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112014020171A2 true BR112014020171A2 (pt) | 2018-04-10 |
| BR112014020171B1 BR112014020171B1 (pt) | 2021-12-21 |
Family
ID=47884392
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014020171-4A BR112014020171B1 (pt) | 2012-02-16 | 2013-02-15 | Uso de um composto, métodos para reduzir o número de campylobacter, prevenir que campylobacter forme um biofilme, prevenir ou reduzir a transmissão de infecção por campylobacter, reduzir a quantidade de campylobacter na carne e para a fabricação de um alimento ou água potável para animais, alimento para animais e composição oral |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US9655912B2 (pt) |
| EP (2) | EP3068384B1 (pt) |
| CN (2) | CN104244940B (pt) |
| BR (1) | BR112014020171B1 (pt) |
| CA (1) | CA2901407C (pt) |
| DK (1) | DK3068384T3 (pt) |
| ES (1) | ES2738632T3 (pt) |
| PL (1) | PL3068384T3 (pt) |
| WO (1) | WO2013121214A1 (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9961886B2 (en) | 2014-08-13 | 2018-05-08 | Akeso Biomedical, Inc. | Antimicrobial compounds and compositions, and uses thereof |
| PL3334440T3 (pl) * | 2015-08-11 | 2021-11-02 | Akeso Biomedical, Inc. | Kompozycje hamujące tworzenie biofilmu wspierające przyrost masy ciała u zwierząt gospodarskich |
| US10653658B2 (en) | 2015-08-11 | 2020-05-19 | Akeso Biomedical, Inc. | Biofilm inhibiting compositions enhancing weight gain in livestock |
| ES2840233T3 (es) | 2017-08-24 | 2021-07-06 | Evonik Operations Gmbh | Reducción de la colonización del sistema gastrointestinal por Campylobacter |
| NL2022942B1 (en) * | 2019-04-15 | 2020-10-22 | Intracare Bv | Use of iron chelate to reduce gastrointestinal tract colonisation by campylobacter |
| CN110218160B (zh) * | 2019-06-19 | 2022-05-24 | 暨南大学 | 一种奎宁酸衍生物及其制备方法与应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2049553A (en) | 1926-11-24 | 1936-08-04 | Raytheon Mfg Co | Electrical condenser |
| US4394451A (en) * | 1980-10-30 | 1983-07-19 | Biomagnetech Corp. | Culture medium and conditions for growth of magnetic bacteria |
| US6024979A (en) | 1995-06-06 | 2000-02-15 | Solvay Animal Health, Inc. | Oral veterinary composition containing a fluoroquinolone antibacterial agent possessing superior absorption properties and an extended duration of therapeutic antimicrobial blood levels, and a method of treating a microbial infection in a ruminant |
| US6242009B1 (en) * | 1999-04-20 | 2001-06-05 | Kareem I. Batarseh | Microbicidal formulations and methods to control microorganisms |
| US7431939B1 (en) | 2000-09-28 | 2008-10-07 | Mississippi State University | Inhibition of systemic infections in humans and vertebrates by dietary fibers |
| SE0103695D0 (sv) * | 2001-11-07 | 2001-11-07 | Thomas Boren | A novel non-antibiotic strategy against OGIP infections based on a cereal product |
| JP5236189B2 (ja) * | 2003-12-05 | 2013-07-17 | チルドレンズ ホスピタル メディカル センター | オリゴ糖組成物および感染症の治療における該組成物の使用 |
| EP3778809B1 (en) | 2004-10-20 | 2023-04-26 | Swimc Llc | Coating compositions for cans and methods of coating |
| GB0423681D0 (en) * | 2004-10-26 | 2004-11-24 | Sec Dep For Environment Food & | Vaccine and nucleic acids |
| JP2006321776A (ja) | 2005-05-18 | 2006-11-30 | Kyuuken:Kk | アミノ酸を配位して成る金属錯体である抗菌防カビ剤とその二次製品 |
| US20070269495A1 (en) * | 2006-05-18 | 2007-11-22 | Ashmead H Dewayne | Compositions and methods for enhancing mineral levels in animals with reduced environmental impact |
| BRPI1013053A2 (pt) | 2009-06-08 | 2016-04-05 | Idemitsu Kosan Co | agente de controle de coccidiose para um animal, aditivo para ração, método para a criação de um animal, e, líquido aquecido da castanha de caju e/ou cardanol |
| US9565857B2 (en) | 2010-09-10 | 2017-02-14 | Board Of Regents, The University Of Texas System | Antimicrobial solutions |
-
2013
- 2013-02-15 CN CN201380020380.9A patent/CN104244940B/zh not_active Expired - Fee Related
- 2013-02-15 ES ES13709500T patent/ES2738632T3/es active Active
- 2013-02-15 US US14/379,473 patent/US9655912B2/en active Active
- 2013-02-15 BR BR112014020171-4A patent/BR112014020171B1/pt not_active IP Right Cessation
- 2013-02-15 EP EP13709500.6A patent/EP3068384B1/en active Active
- 2013-02-15 WO PCT/GB2013/050367 patent/WO2013121214A1/en active Application Filing
- 2013-02-15 CA CA2901407A patent/CA2901407C/en active Active
- 2013-02-15 PL PL13709500T patent/PL3068384T3/pl unknown
- 2013-02-15 DK DK13709500.6T patent/DK3068384T3/da active
- 2013-02-15 CN CN201810240700.6A patent/CN108524524B/zh not_active Expired - Fee Related
- 2013-02-15 EP EP19164659.5A patent/EP3569230A1/en not_active Withdrawn
-
2017
- 2017-03-14 US US15/458,177 patent/US10195172B2/en active Active
-
2018
- 2018-08-06 US US16/055,935 patent/US20190083447A1/en not_active Abandoned
-
2019
- 2019-02-04 US US16/266,946 patent/US20190314323A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ES2738632T3 (es) | 2020-01-24 |
| US20170231945A1 (en) | 2017-08-17 |
| WO2013121214A1 (en) | 2013-08-22 |
| EP3068384A1 (en) | 2016-09-21 |
| EP3068384B1 (en) | 2019-05-08 |
| US9655912B2 (en) | 2017-05-23 |
| US20190083447A1 (en) | 2019-03-21 |
| BR112014020171B1 (pt) | 2021-12-21 |
| CA2901407C (en) | 2021-11-23 |
| CN104244940A (zh) | 2014-12-24 |
| US20150025026A1 (en) | 2015-01-22 |
| US10195172B2 (en) | 2019-02-05 |
| EP3569230A1 (en) | 2019-11-20 |
| CN108524524B (zh) | 2021-03-19 |
| DK3068384T3 (da) | 2019-08-12 |
| CA2901407A1 (en) | 2013-08-22 |
| US20190314323A1 (en) | 2019-10-17 |
| PL3068384T3 (pl) | 2019-11-29 |
| CN104244940B (zh) | 2018-07-20 |
| CN108524524A (zh) | 2018-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014020171A2 (pt) | método para desinfecção de um animal, método para reduzir a quantidade de campylobacter na carne, método para identificar um composto para uso na desinfecção de animais, prevenção ou redução da adesão de campylobacter à parede intestinal ou no tratamento de infecção por campylobacter em humanos ou animais, alimento animal, ingrediente de alimento ou suplemento alimentar, método para desinfectar um gênero alimentício, composto, uso de um composto e kit | |
| BR112018006048A2 (pt) | drone agrícola para o uso no monitoramento de gado | |
| BRPI0823271A2 (pt) | Chip de dna, kit para detecção ou para genotipagem de bactérias que causam doenças sexualmente transmitidas, genotipagem de resistência a fármacos antibacterianos e método de detecção ou de genotipagem das mesmas. | |
| BR112013014708A2 (pt) | composto, composição farmacêutica, e, método de inibir ou modular a atividade da cinase de proteína em uma amostra biológica | |
| BRPI1009860A2 (pt) | composto, uso do mesmo, composição farmacêutica e método para tratamento terapêutico ou prevenção de doenças em humanos ou animais | |
| DK3508064T3 (da) | System and method for processing slaughtered animals and/or parts thereof | |
| BR112015031475A2 (pt) | composto, composição farmacêutica, método para tratamento de uma doença ou condição, kit, e, uso de composto. | |
| BRPI0820568A2 (pt) | Composto, composição farmacêutica, uso de um composto ou uma composição farmacêutica, e, método de tratamento de um humano ou animal | |
| BR112014011251B8 (pt) | alimentos para animais de estimação | |
| CL2014002348A1 (es) | Compuestos derivados de fenicol; composicion farmaceutica que los comprende; y su uso para controlar o tratar infecciones bacterianas en ganado. | |
| BRPI0923855A2 (pt) | Ácido lipóico, e, composição de ração de animal de estimação. | |
| BRPI0919340A2 (pt) | sistemas e métodos para prover produtos e animais | |
| BRPI0812524A2 (pt) | Amidohidrolases para a preparação de gêneros alimentícios ou estimulantes | |
| BRPI1010302A2 (pt) | composições e métodos para tratamento, inibição ou prevenção do desenvolvimento de uma doença patogênica de planta e método de extermínio, inibição ou prevenção do desenvolvimento de um organismo | |
| BRPI0820068A2 (pt) | Composição para nutrição humana e/ou animal, usos derivados e leveduras | |
| BRPI0909447A2 (pt) | Composição, métodos para tratar um indivíduo humano ou animal em necessidade de tal tratamento e para matar ou inibir o crescimento de microrganismos suscetíveis, e, uso de uma composição | |
| BRPI0912733A2 (pt) | sistema e método para processamento de alimento | |
| BRPI0820850A2 (pt) | Formulação de ração para animais de estimação | |
| BRPI0921363A2 (pt) | sala giratória para ordenha de animais | |
| ZA201601752B (en) | Functional protein derived from animal muscle tissue or mechanically deboned meat and method for making the same | |
| BR112014029191A2 (pt) | método de superfície que pasteuriza ou estereliza alimentos particulados de baixa hidratação e sistema para pasteurizar ou esterelizar alimentos | |
| BRPI0907561A2 (pt) | Materiais e métodos para aperfeiçoamento da saúde de camarões | |
| BR112012022727A2 (pt) | uso de um ou mais agentes quelantes, composição nutricional, e métodos para prover nutricição a uma pessoa em necessidade da mesma | |
| BRPI1010300A2 (pt) | processos para a preparação de um composto, para perparar dronedarone, ou um sal do mesmo, e para preparar uma formulação farmacêutica. | |
| BRPI0817156A2 (pt) | Matéria gorda láctea de ruminante, método de obtenção da matéria gorda láctea de ruminante e composição alimentar |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 15/02/2013, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 11A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2762 DE 12-12-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |